The expression levels of VEGF and Flt-1 in the patients with lymph node metastasis were 85.7 and 78.6%, respectively, evidently higher than those in the patients without lymph node metastasis; the two differences were significant (P=0.009; P=0.02). This evidence concerns the gene FLT1 and metastatic malignant neoplasm in the lymph nodes.